Hanlon Investment Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,978
Closed -$219K 140
2021
Q1
$219K Sell
3,978
-2,358
-37% -$131K 0.05% 123
2020
Q4
$346K Buy
6,336
+486
+8% +$25.4K 0.07% 98
2020
Q3
$292K Sell
5,850
-10,752
-65% -$521K 0.09% 92
2020
Q2
$733K Buy
+16,602
New +$709K 0.21% 58

Other funds holding IHI

Hanlon Investment Management's IHI Position: Q2 2021 in Review

Hanlon Investment Management sold out of iShares US Medical Devices ETF (IHI) in Q2 2021, closing a stake of 3,978 shares — an estimated $219K sold.

Hanlon Investment Management first reported a position in IHI in Q2 2020 and held it in 4 quarters. The position peaked at $733K in Q2 2020. 559 funds tracked by Wall St. Rank hold IHI as of Q2 2021.

  • Hanlon Investment Management reported no remaining iShares US Medical Devices ETF position as of Q2 2021 after selling out during the quarter.
  • Hanlon Investment Management sold 3,978 iShares US Medical Devices ETF shares in Q2 2021, an estimated $219K.
  • Hanlon Investment Management first reported a position in iShares US Medical Devices ETF in Q2 2020 and held it in 4 quarters.
  • Hanlon Investment Management's iShares US Medical Devices ETF position peaked at $733K in Q2 2020.
  • 559 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2021.

Based on Hanlon Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.